Fm. Wagner et al., HOW SUCCESSFUL IS OKT3 RESCUE THERAPY FOR STEROID-RESISTANT ACUTE REJECTION EPISODES AFTER HEART-TRANSPLANTATION, The Journal of heart and lung transplantation, 13(3), 1994, pp. 438-443
OKT3 is recommended as rescue therapy for cases of steroid-resistant,
clinically persistant acute rejection episodes after heart transplanta
tion. In this study we determined the efficacy of such treatment. One
hundred thirty-two patients were included in this study. The postopera
tive immunosuppressive regimen consisted of triple-drug therapy and pe
rioperative antithymocyte globulin. During a follow-up of 10 to 108 we
eks (mean, 51 +/- 20 weeks) 281 treatment-requiring acute rejection ep
isodes (International Society for Heart and Lung Transplantation great
er-than-or-equal-to II) were observed. In 29 cases (10.3%) the grade o
f the acute rejection episodes was either unchanged after two series o
f intravenous steroid pulse therapy, was worsened after the first ster
oid course, or the patient experienced clinical deterioration as a res
ult of the acute rejection episodes. These patients were considered to
have steroid-resistant acute rejection episodes and received a 10-day
rescue therapy with OKT3, followed by control endomyocardial biopsy.
In 17 cases, control endomyocardial biopsy revealed normal myocardium
(group I). In 10 cases acute rejection episodes remained unchanged (gr
oup II); twice a deterioration was found (group III). However, 12 of t
he 17 patients from group I experienced a rebound of the acute rejecti
on episodes (International Society for Heart and Lung Transplantation
greater-than-or-equal-to II) 1 to 3 weeks later. Side effects of OKT3
treatment were fever, chills, intestinal complications, hemodynamic re
sponse, convulsions, and viral infections. Complete remission of stero
id-resistant acute rejection episodes by OKT3 rescue therapy was there
fore only achieved in five patients (17.2%), in all other cases furthe
r treatment of the acute rejection episodes with methotrexate was nece
ssary. As a result from this study routine OKT3 rescue therapy has bee
n discontinued at our center and remains restricted to particular case
s.